Work

47 POSTER A phase II study of Sorafenib (BAY 43-9006) in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal cancer (NPC): final results

Year: 2006

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(06)70053-2

Authors: C. Elser, L. Siu, E. Winquist, M. Agulnik, G. Pond, S. Chin, P. Francis, R. Cheiken, O. Petrenciuc, E. Chen

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2041008604

Cites:

Cited by:

Related to: 10